1. Home
  2. ALKS
  3. ALKS News

Latest Alkermes plc (ALKS) News on July 27, 2024

ALKS

MT Newswires

a day ago

JPMorgan Adjusts Price Target on Alkermes to $32 From $31, Maintains Neutral Rating

Alkermes' (ALKS) Q2 Earnings Miss Estimates, Revenues Beat
ALKS

Zacks

a day ago

Alkermes' (ALKS) Q2 Earnings Miss Estimates, Revenues Beat

ALKS

MT Newswires

a day ago

HC Wainwright Adjusts Price Target on Alkermes to $37 From $35, Maintains Neutral Rating

ALKS

MT Newswires

a day ago

Baird Adjusts Price Target on Alkermes to $38 From $37, Maintains Outperform Rating

Alkermes (ALKS) Reports Q2 Earnings: What Key Metrics Have to Say
ALKS

Zacks

2 days ago

Alkermes (ALKS) Reports Q2 Earnings: What Key Metrics Have to Say

Alkermes (ALKS) Lags Q2 Earnings Estimates
ALKS

Zacks

3 days ago

Alkermes (ALKS) Lags Q2 Earnings Estimates

ALKS

MT Newswires

3 days ago

Alkermes Q2 Adjusted Earnings Rise, Revenue Falls

Is Alkermes plc's (NASDAQ:ALKS) Latest Stock Performance Being Led By Its Strong Fundamentals?
ALKS

Simply Wall St.

3 days ago

Is Alkermes plc's (NASDAQ:ALKS) Latest Stock Performance Being Led By Its Strong Fundamentals?

ALKS

Associated Press Finance

3 days ago

Alkermes: Q2 Earnings Snapshot

Alkermes plc Reports Second Quarter 2024 Financial Results
ALKS

PR Newswire

3 days ago

Alkermes plc Reports Second Quarter 2024 Financial Results

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
ALKS

Zacks

7 days ago

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for

Alkermes to Report Second Quarter Financial Results on July 24, 2024
ALKS

PR Newswire

9 days ago

Alkermes to Report Second Quarter Financial Results on July 24, 2024

Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q2 Release
ALKS

Zacks

9 days ago

Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q2 Release

ALKS

MT Newswires

11 days ago

JPMorgan Trims Price Target on Alkermes to $31 From $32, Maintains Neutral Rating

Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
ALKS

Zacks

a month ago

Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?

ALKS

MT Newswires

a month ago

TD Cowen Initiates Alkermes at Buy With $34 Price Target

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
ALKS

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
ALKS

Business Wire

2 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
ALKS

AFP

2 months ago

New Zealand scraps plan to tax livestock burps, farts

ALKS

Business Wire

2 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
ALKS

The Wall Street Journal

2 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool
ALKS

Bloomberg

2 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
ALKS

Simply Wall St.

2 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors
ALKS

Simply Wall St.

2 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024
ALKS

PR Newswire

2 months ago

Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024

Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
ALKS

Zacks

2 months ago

Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?

Alkermes to Participate in Two Upcoming Investor Conferences
ALKS

PR Newswire

2 months ago

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
ALKS

PR Newswire

2 months ago

Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024

ALKS

MT Newswires

2 months ago

Cantor Fitzgerald Adjusts Alkermes Price Target to $48 From $43, Maintains Overweight Rating

Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
ALKS

Zacks

2 months ago

Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
ALKS

PR Newswire

2 months ago

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
ALKS

Zacks

3 months ago

Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates

ALKS

MT Newswires

3 months ago

UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
ALKS

PR Newswire

3 months ago

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk

ALKS

MT Newswires

3 months ago

Alkermes's Q1 Earnings, Revenue Grow But Miss Street View

Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
ALKS

Zacks

3 months ago

Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say

Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
ALKS

Zacks

3 months ago

Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates

ALKS

Associated Press Finance

3 months ago

Alkermes: Q1 Earnings Snapshot

Alkermes plc Reports First Quarter 2024 Financial Results
ALKS

PR Newswire

3 months ago

Alkermes plc Reports First Quarter 2024 Financial Results

How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?
ALKS

Investor's Business Daily

3 months ago

How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?

Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ALKS

Zacks

3 months ago

Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
ALKS

PR Newswire

3 months ago

Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1

Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
ALKS

Zacks

3 months ago

Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?

Alkermes to Report First Quarter Financial Results on May 1, 2024
ALKS

PR Newswire

3 months ago

Alkermes to Report First Quarter Financial Results on May 1, 2024

Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q1 Release
ALKS

Zacks

3 months ago

Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
ALKS

Zacks

3 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study
ALKS

Zacks

3 months ago

Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study

Alkermes' Innovations Are Transforming Mental Health Treatments
ALKS

GuruFocus.com

3 months ago

Alkermes' Innovations Are Transforming Mental Health Treatments

Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term
ALKS

Zacks

4 months ago

Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term

ALKS

Associated Press Finance

4 months ago

BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
ALKS

PR Newswire

4 months ago

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
ALKS

PR Newswire

4 months ago

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

Why Alkermes (ALKS) is Poised to Beat Earnings Estimates Again
ALKS

Zacks

4 months ago

Why Alkermes (ALKS) is Poised to Beat Earnings Estimates Again

Investors in Alkermes (NASDAQ:ALKS) have seen favorable returns of 44% over the past three years
ALKS

Simply Wall St.

4 months ago

Investors in Alkermes (NASDAQ:ALKS) have seen favorable returns of 44% over the past three years

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
ALKS

Zacks

4 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
ALKS

Zacks

4 months ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
ALKS

Zacks

4 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Insider Sell: SVP, Chief Commercial Officer Christian Nichols Sells Shares of Alkermes PLC (ALKS)
ALKS

GuruFocus.com

4 months ago

Insider Sell: SVP, Chief Commercial Officer Christian Nichols Sells Shares of Alkermes PLC (ALKS)

Alkermes (ALKS) Stock Moves -0.45%: What You Should Know
ALKS

Zacks

4 months ago

Alkermes (ALKS) Stock Moves -0.45%: What You Should Know

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
ALKS

Investor's Business Daily

4 months ago

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

3 Reasons Why Alkermes (ALKS) Is a Great Growth Stock
ALKS

Zacks

4 months ago

3 Reasons Why Alkermes (ALKS) Is a Great Growth Stock

Here's Why Alkermes (ALKS) is a Strong Momentum Stock
ALKS

Zacks

4 months ago

Here's Why Alkermes (ALKS) is a Strong Momentum Stock

Here's Why Alkermes (ALKS) is a Strong Growth Stock
ALKS

Zacks

5 months ago

Here's Why Alkermes (ALKS) is a Strong Growth Stock

Why Alkermes (ALKS) Outpaced the Stock Market Today
ALKS

Zacks

5 months ago

Why Alkermes (ALKS) Outpaced the Stock Market Today

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
ALKS

PR Newswire

5 months ago

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

Alkermes (ALKS) Stock Declines While Market Improves: Some Information for Investors
ALKS

Zacks

5 months ago

Alkermes (ALKS) Stock Declines While Market Improves: Some Information for Investors

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
ALKS

Zacks

5 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Why Alkermes (ALKS) is a Top Momentum Stock for the Long-Term
ALKS

Zacks

5 months ago

Why Alkermes (ALKS) is a Top Momentum Stock for the Long-Term

Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term
ALKS

Zacks

5 months ago

Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term

Alkermes Full Year 2023 Earnings: Beats Expectations
ALKS

Simply Wall St.

5 months ago

Alkermes Full Year 2023 Earnings: Beats Expectations

Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript
ALKS

Insider Monkey

5 months ago

Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript

Alkermes Stock Gets RS Rating Upgrade; Profits Surge
ALKS

Investor's Business Daily

5 months ago

Alkermes Stock Gets RS Rating Upgrade; Profits Surge

Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates
ALKS

Zacks

5 months ago

Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates

Compared to Estimates, Alkermes (ALKS) Q4 Earnings: A Look at Key Metrics
ALKS

Zacks

5 months ago

Compared to Estimates, Alkermes (ALKS) Q4 Earnings: A Look at Key Metrics

Alkermes PLC (ALKS) Reports Strong 2023 Financial Results and Sets Positive Outlook for 2024
ALKS

GuruFocus.com

5 months ago

Alkermes PLC (ALKS) Reports Strong 2023 Financial Results and Sets Positive Outlook for 2024

ALKS

Associated Press Finance

5 months ago

Alkermes: Q4 Earnings Snapshot

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
ALKS

PR Newswire

5 months ago

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ALKS

Zacks

5 months ago

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Exploring Analyst Estimates for Alkermes (ALKS) Q4 Earnings, Beyond Revenue and EPS
ALKS

Zacks

5 months ago

Exploring Analyst Estimates for Alkermes (ALKS) Q4 Earnings, Beyond Revenue and EPS

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024
ALKS

PR Newswire

6 months ago

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024

Alkermes (ALKS) to Report Q4 Results: Wall Street Expects Earnings Growth
ALKS

Zacks

6 months ago

Alkermes (ALKS) to Report Q4 Results: Wall Street Expects Earnings Growth

Alkermes (ALKS) Stock Falls Amid Market Uptick: What Investors Need to Know
ALKS

Zacks

6 months ago

Alkermes (ALKS) Stock Falls Amid Market Uptick: What Investors Need to Know

ALKS

Argus Research

6 months ago

Market Update: AMZN, ETN, ITW, MKTX, SKX, FBIN, PTON

Analysts Are Upbeat About Skechers Despite Company’s Wholesale Challenges
ALKS

Footwear News

6 months ago

Analysts Are Upbeat About Skechers Despite Company’s Wholesale Challenges

Cybersecurity Stock Partners With Heavyweights Microsoft, Amazon, Google
ALKS

Investor's Business Daily

6 months ago

Cybersecurity Stock Partners With Heavyweights Microsoft, Amazon, Google

Tetra Tech (TTEK) Beats on Q1 Earnings, Raises 2024 Guidance
ALKS

Zacks

6 months ago

Tetra Tech (TTEK) Beats on Q1 Earnings, Raises 2024 Guidance

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
ALKS

InvestorPlace

6 months ago

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024

Alkermes (ALKS) Stock Dips While Market Gains: Key Facts
ALKS

Zacks

6 months ago

Alkermes (ALKS) Stock Dips While Market Gains: Key Facts

3 Top Pharma Stocks to Buy Now: February 2024
ALKS

InvestorPlace

6 months ago

3 Top Pharma Stocks to Buy Now: February 2024

Labcorp (LH) Unveils Test for Preeclampsia in Pregnant Women
ALKS

Zacks

6 months ago

Labcorp (LH) Unveils Test for Preeclampsia in Pregnant Women

Will Wynn (WYNN) Beat Estimates Again in Its Next Earnings Report?
ALKS

Zacks

6 months ago

Will Wynn (WYNN) Beat Estimates Again in Its Next Earnings Report?

AptarGroup (ATR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ALKS

Zacks

6 months ago

AptarGroup (ATR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
ALKS

Zacks

6 months ago

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Wix to Announce Fourth Quarter and Full Year 2023 Results on February 21, 2024
ALKS

PR Newswire

6 months ago

Wix to Announce Fourth Quarter and Full Year 2023 Results on February 21, 2024

ALKS

Argus Research

6 months ago

Analyst Report: Oshkosh Corp

ALKS

Argus Research

6 months ago

Market Digest: GLW, OSK, SAP, UPS, URI, MSCI, AGNC

ALKS

Business Wire

6 months ago

Evercore Reports Fourth Quarter and Full Year 2023 Results; Quarterly Dividend of $0.76 Per Share

If EPS Growth Is Important To You, Oshkosh (NYSE:OSK) Presents An Opportunity
ALKS

Simply Wall St.

6 months ago

If EPS Growth Is Important To You, Oshkosh (NYSE:OSK) Presents An Opportunity

Vaxcyte Announces Pricing of $750 Million Public Offering
ALKS

GlobeNewswire

6 months ago

Vaxcyte Announces Pricing of $750 Million Public Offering

Why Alkermes (ALKS) Could Beat Earnings Estimates Again
ALKS

Zacks

6 months ago

Why Alkermes (ALKS) Could Beat Earnings Estimates Again

Share on Social Networks: